Monday, September 5, 2011

Artificial lung mimics real organ's design and efficiency: Small device works with air, pure oxygen not needed

ScienceDaily (July 25, 2011) — An artificial lung built by Cleveland researchers has reached efficiencies akin to the genuine organ, using air -- not pure oxygen as current human-made lungs require -- for the source of the essential element.See Also:Health & MedicineLung DiseaseLung CancerCystic FibrosisDiseases and ConditionsMedical ImagingDisabilityReferenceArtificial heartEmphysemaOxygen therapyLung

Use in humans is still years away, but for the 200 million lung disease sufferers worldwide, the device is a major step toward creating an easily portable and implantable artificial lung, said Joe Potkay, a research assistant professor in electrical engineering and computer science at Case Western Reserve University. Potkay is the lead author of the paper describing the device and research, in the journal Lab on a Chip.

The scientists built the prototype device by following the natural lung's design and tiny dimensions. The artificial lung is filled with breathable silicone rubber versions of blood vessels that branch down to a diameter less than one-fourth the diameter of human hair.

"Based on current device performance, we estimate that a unit that could be used in humans would be about 6 inches by 6 inches by 4 inches tall, or about the volume of the human lung. In addition, the device could be driven by the heart and would not require a mechanical pump," Potkay said.

Current artificial lung systems require heavy tanks of oxygen, limiting their portability. Due to their inefficient oxygen exchange, they can be used only on patients at rest, and not while active. And, the lifetime of the system is measured in days.

The Cleveland researchers focused first on improving efficiency and portability.

Potkay, who specializes in micro- and nano-technology, worked with Brian Cmolik, MD, an assistant clinical professor at Case Western Reserve School of Medicine and researcher at the Advanced Platform Technology Center and the Cardiothoracic Surgery department at the Louis Stokes Cleveland VA Medical Center. Michael Magnetta and Abigail Vinson, biomedical engineers and third-year students at Case Western Reserve University School of Medicine, joined the team and helped develop the prototype during the past two years.

The researchers first built a mould with miniature features and then layered on a liquid silicone rubber that solidified into artificial capillaries and alveoli, and separated the air and blood channels with a gas diffusion membrane.

By making the parts on the same scale as the natural lung, the team was able to create a very large surface-area-to-volume ratio and shrink the distances for gas diffusion compared to the current state of the art. Tests using pig blood show oxygen exchange efficiency is three to five times better, which enables them to use plain air instead of pure oxygen as the ventilating gas.

Potkay's team is now collaborating with researchers from Case Western Reserve's departments of biomedical engineering and chemical engineering to develop a coating to prevent clogging in the narrow artificial capillaries and on construction techniques needed to build a durable artificial lung large enough to test in rodent models of lung disease.

Within a decade, the group expects to have human-scale artificial lungs in use in clinical trials.

They envision patients would tap into the devices while allowing their own diseased lungs to heal, or maybe implant one as a bridge while awaiting a lung transplant -- a wait that lasts, on average, more than a year.

Email or share this story:

Pacific Northwest trees struggle for water while standing in it

ScienceDaily (July 25, 2011) — Contrary to expectations, researchers have discovered that the conifers of the Pacific Northwest, some of the tallest trees in the world, face their greatest water stress during the region's eternally wet winters, not the dog days of August when weeks can pass without rain.See Also:Plants & AnimalsTreesDroughtBotanyEarth & ClimateWaterForestDrought ResearchReferenceCoast Douglas-firGrowth ringOld growth forestSequoia tree

Due to freeze-thaw cycles in winter, water flow is disrupted when air bubbles form in the conductive xylem of the trees. Because of that, some of these tall conifers are seriously stressed for water when they are practically standing in a lake of it, scientists from Oregon State University and the U.S. Forest Service concluded in a recent study.

It's not "drought stress" in a traditional sense, the researchers said, but the end result is similar. Trees such as Douglas-fir actually do better dealing with water issues during summer when they simply close down their stomata, conserve water and reduce their photosynthesis and growth rate.

"Everyone thinks that summer is the most stressful season for these trees, but in terms of water, winter can be even more stressful," said Katherine McCulloh, a research assistant professor in the OSU Department of Forest Ecosystems and Society.

"We've seen trees in standing water, at a site that gets more than two meters of rain a year, yet the xylem in the small branches at the tops of these trees can't transport as much water as during the summer," McCulloh said.

The ease with which water moves through wood is measured as the "hydraulic conductivity," and researchers generally had believed this conductivity would be the lowest during a conventional drought in the middle of summer. They found that wasn't the case.

"We thought if there was a serious decline in conductivity it would have been from drought," said Rick Meinzer, a researcher with the Pacific Northwest Research Station of the USDA Forest Service, as well as OSU. "It was known that air bubbles could form as increased tension is needed in the xylem to pull water higher and higher. But it turns out that freezing and thawing caused the most problems for water transport."

Studies such as this are important, the scientists said, to better understand how forests might respond to a warmer or drier climate of the future. And although this might imply that these conifers could be more resistant to drought than had been anticipated, the researchers said it's not that simple.

"If the climate warms, we might actually get more of these winter cycles of freezing and thawing," McCulloh said. "There's a lot of variability in the effects of climate we still don't understand.

"One of the most amazing things these trees can do is recover from these declines in conductivity by replacing the air bubbles with water," she said. "We don't understand how they do that at the significant tensions that exist at those heights. We're talking about negative pressures or tensions roughly three times the magnitude of what you put in your car tires."

When the field research on this study was done in 2009, the area actually experienced a historic heat wave during August when temperatures in the Willamette Valley hit 108 degrees. During such extreme heat, trees experienced some loss of hydraulic conductivity but largely recovered even before rains came in September. By contrast, greater loss of hydraulic conductivity was observed in the middle of winter.

The study was done at the Wind River Canopy Crane Research Facility, and published in the American Journal of Botany. The research was supported by the National Science Foundation.

"The commonly held view is that the summer months of the Pacific Northwest are extremely stressful to plants," the researchers wrote in their conclusion.

"Yet, our results indicated that the winter months are more stressful in terms of hydraulic function, and suggest that perhaps an inability to recover from increase in native embolism rates over the winter may cause greater branch dieback in old-growth trees than shifts in summer climate."

Email or share this story:

Sunday, September 4, 2011

Predictors of dying suddenly versus surviving heart attack identified

ScienceDaily (July 25, 2011) — Is it possible to predict whether someone is likely to survive or die suddenly from a heart attack? A new study by researchers at Wake Forest Baptist Medical Center has answered just that.See Also:Health & MedicineHeart DiseaseCholesterolStroke PreventionMind & BrainStrokeMultiple SclerosisSchizophreniaReferenceIschaemic heart diseaseCoronary heart diseaseCardiac arrestEchocardiography

"For some people, the first heart attack is more likely to be their last," said Elsayed Z. Soliman, M.D., M.Sc., M.S., director of the Epidemiological Cardiology Research Center (EPICARE) at Wake Forest Baptist and lead author of the study. "For these people especially, it is important that we find ways to prevent that first heart attack from ever happening because their chances of living through it are not as good."

While there are many traits that are common among heart attack patients -- both those who survive the event and those who die suddenly -- researchers found that some traits, such as hypertension, race/ethnicity, body mass index (BMI), heart rate, and additional markers that can be identified by an electrocardiogram (ECG) can differentiate between dying suddenly versus living through a heart attack, Soliman said.

The study, published by the journal Heart, is now available online.

Somewhere between 230,000 and 325,000 people in the U.S. succumb to sudden cardiac death every year, Soliman said. Most of these sudden deaths are caused by coronary heart disease.

"Since sudden cardiac death usually occurs before patients ever make it to the hospital, there is very little that can be done to save them," Soliman said. "Identifying specific predictors that separate the risk of sudden cardiac death from that of non-fatal or not immediately fatal heart attacks would be the first step to address this problem, which was the basis for our study."

Researchers analyzed data from two of the largest U.S. cardiovascular studies -- the ARIC (Atherosclerosis Risk in Communities) and the CHS (Cardiovascular Health Study) -- containing records for more than 18,000 participants. After taking into account common risk factors for coronary heart disease and the competing risk of sudden cardiac death with coronary heart disease, they found that:

Black race/ethnicity (compared to non-black) was predictive of high sudden cardiac death risk, but less risk of coronary heart disease. Hypertension and increased heart rate were stronger predictors of high risk of sudden cardiac death compared to coronary heart disease. Extreme high or low body mass index was predictive of increased risk of sudden cardiac death but not of coronary heart disease. Additional, more technical traits that a doctor evaluating an ECG report could use to evaluate risk of sudden cardiac death in their patients. (Prolongation of QTc and abnormally inverted T wave were stronger predictors of high risk of sudden cardiac death. On the other hand, elevated electrocardiographic ST height in V2 was not predictive of sudden cardiac death but predictive of coronary heart disease.)

If the results are validated and confirmed in other studies, Soliman predicts that doctors will have a way to identify patients who are at greater risk of dying suddenly if they experience a heart attack and, therefore, a group of patients for whom early intervention, including risk factor modification, may be a life-saving option.

"Our next step in this path of research is to see if we can come up with a risk stratification score that can be applied to the general population, as well as to look at interventions that reverse the effect that these traits are having on susceptibility to sudden cardiac death," Soliman said. "We need to know if lowering hypertension, BMI or resting heart rate would reduce the risk of dying suddenly."

The study was funded by the Donald W. Reynolds Cardiovascular Clinical Research Center at the Johns Hopkins University School of Medicine. The ARIC and CHS studies are supported by the National Heart, Lung, and Blood Institute.

Email or share this story:

Gray Platelet Syndrome: Elusive gene that makes platelets gray identified

ScienceDaily (July 25, 2011) — Researchers have identified an elusive gene responsible for Grey Platelet Syndrome, an extremely rare blood disorder in which only about 50 known cases have been reported. As a result, it is hoped that future cases will be easier to diagnose with a DNA test.See Also:Health & MedicineGenesBirth DefectsDiseases and ConditionsHuman BiologyBlood ClotsGene TherapyReferenceHaemophiliaLeukemiaAlleleStroke

The findings were made following a collaborative study by Professor Willem Ouwehand and Dr Cornelis Albers, who are both based at the Wellcome Trust Sanger Institute and the University of Cambridge, and Dr Paquita Nurden, from the Rare Platelet Disorders laboratory, based in Bordeaux, who have described their study.

Platelets are the second most abundant cell in the blood. Their main task is to survey the blood vessel wall for damage and to orchestrate its repair where required. On the flip side, platelets also play a "darker" role after vessel wall damage and cause blood clots that may lead to heart attacks or stroke.

Some people are born with platelets that do not function well and these rare conditions are thought to be inherited. Grey Platelet Syndrome poses a risk of bleeds, some of which can be severe and life threatening, e.g. if they occur in the brain. Grey Platelet Syndrome was first identified in the 1970s and is named for the greyish appearance of these platelets when viewed with a microscope.

Identifying the cause of increased bleeding in young patients has been a painstaking process. An important step in translating research findings in human genetics in improvements of patient care has focused around the need to develop simpler and rapid DNA-based diagnostic test. To achieve this, researchers needed to discover the gene responsible for the rare platelet bleeding disorders.

In the past it was a major challenge to discover which genes caused rare disorders because DNA samples from numerous large families affected by the same disorder had to be identified and genetically analysed to pinpoint the region harbouring the causative gene.

To achieve their latest findings, researchers used a simpler approach and deciphered about 40 million letters of genetic code covering the entire coding fraction of the genome of four non-related French patients.

They identified the gene NBEAL2 as not functioning well in Grey Platelet Syndrome, a member of a family of genes that all contain a unique domain, called the BEACH domain. The team showed that protein encoded by this gene is altered at a different position in the four non-related cases and the patients affected by the disorder have inherited two non-functioning copies of the gene, one from father and mother each.

"It is really great to see how the use of modern genomics technologies is going to be of direct benefit for patient care. It is exciting that we have shown that the genetic basis of a rare bleeding disorder can be discovered with relative ease," said Professor Willem Ouwehand, who heads a NHS Blood and Transplant research team on platelet biology at both the Wellcome Trust Sanger Institute and the University of Cambridge. "This study is one such example and it gives us confidence to achieve the same for a large number of other rare inherited platelet bleeding disorders. It is now important that we use this discovery to improve patient care in the NHS and beyond."

The team's identification of the NBEAL2 gene was confirmed by functional studies in zebrafish. Fish also have platelets named thrombocytes, and switching off the NBEAL2 gene in fish caused a complete absence of these cells which resulted in nearly half of the fish suffering spontaneous bleeds similar to patients with the disorder.

It is hoped that this gene identification will make it simpler to diagnose future cases of Grey Platelet Syndrome with a simple DNA test. This new test is now being developed with researchers at the NHS Blood and Transplant Centre at the Addenbrooke's Biomedical campus in Cambridge as part of the international ThromboGenomics initiative.

The scientists also observed that other members from the same family of BEACH proteins are implicated in other rare inherited disorders. Their findings showed that LYST protein did not function well in Chediak-Higashi syndrome, another rare but severe disorder paralysing the immune system but also causing a mild platelet bleeding disorder. As a result, a picture is emerging that BEACH proteins are essential in the way granules in blood cells and brain cells are formed or retained showing that in platelets the BEACH proteins are essential for both alpha and dense granules.

"Our discovery that another member of the family of BEACH proteins is underlying a rare but severe granule disorder in platelets firmly nails down the important role of this class of proteins in granule biology," said Cornelis Albers, a British Heart Foundation research fellow at the Sanger Institute and the University of Cambridge. "The reasons why the platelets of patients with Grey Platelet Syndrome are grey is because they lack alpha granules. The alpha granules carry the cargo of proteins that induce vessel wall repair and also form the platelet plug.

"A better understanding of how these granules are formed and how their timely release by the platelet is coordinated at the molecular level may one day underpin the development of a new class of safer anti-platelet drugs for use in patients with heart attacks and stroke. It has been a fascinating journey to identify a new and important pathway by combining the rapid advances in sequencing technology with computational analysis."

The French collaboration leader, Dr Paquita Nurden, set up the Network for Rare Platelet Disorders at the Laboratoire d'Hématologie, Hopital Xavier Arnozan close to Bordeaux. Their team made the Heruclian effort to find the French families affected by this rare disorder.

"We have worked for years to identify the families across France that suffer from rare platelet disorders and my group of scientists have used powerful microscopes to determine what was wrong with the platelets from patients with Grey Platelet Syndrome. Researchers across the world discovered in the 1980s that something was wrong with the alpha granules because they were lacking in most of the cases," said Dr Nurden, an international expert in platelet biology. "The gene, however, remained elusive for another 30 years, and it is great how our joint working has discovered the causative gene very quickly."

Email or share this story:

Harmful effects of hypothyroidism on maternal and fetal health drive new guidelines for managing thyroid disease in pregnancy

ScienceDaily (July 25, 2011) — Emerging data clarifying the risks of insufficient thyroid activity during pregnancy on the health of the mother and fetus, and on the future intellectual development of the child, have led to new clinical guidelines for diagnosing and managing thyroid disease during this critical period. The guidelines, developed by an American Thyroid Association (ATA) expert task force, are presented in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc.See Also:Health & MedicineThyroid DiseaseHormone DisordersPregnancy and ChildbirthDiseases and ConditionsCancerGynecologyReferenceHypothyroidismHyperthyroidismThyroid hormoneThyroid

Clinical studies are producing critical data demonstrating the harmful effects not only of overt hypothyroidism and hyperthyroidism on pregnancy, but also of subclinical thyroid disease and maternal and fetal health. Ongoing research is clarifying the link between miscarriage and preterm delivery in women with normal thyroid function who are thyroid peroxidase antibody positive. Studies are also uncovering the long-term effects of postpartum thyroiditis.

"Pregnancy has a profound impact on the thyroid gland and thyroid function…. In essence, pregnancy is a stress test for the thyroid, resulting in hypothyroidism in women with limited thyroidal reserve or iodine deficiency," state Alex Stagnaro-Green, George Washington University School of Medicine and Health Sciences (Washington, DC), and coauthors representing the ATA task force.

Among the many specific recommendations detailed in the guidelines are the following: women with overt hypothyroidism or with subclinical hypothyroidism who are TPO antibody positive should be treated with oral levothyroxine; use of other thyroid preparations such as triiodothyronine or desiccated thyroid to treat maternal hypothyroidism is strongly recommended against; and women with subclinical hypothyroidism in pregnancy who are not initially treated should be monitored for progression to overt hypothyroidism with serum TSH and free T4 measurements about every 4 weeks until 16-20 weeks gestation and at least once between 26-32 weeks gestation.

The new clinical guidelines focus on several key areas in the diagnosis and management of thyroid disease during pregnancy and postpartum: thyroid function tests, hypothyroidism, thyrotoxicosis, iodine, thyroid antibodies and miscarriage/preterm delivery, thyroid nodules and cancer, postpartum thyroiditis, recommendations on screening for thyroid disease during pregnancy, and areas for future research.

"These important guidelines were developed by a panel of international experts representing the disciplines of endocrinology, obstetrics and gynecology, and nurse midwives. This broad representation of providers that care for pregnant women will significantly increase the impact of these guidelines and translation of findings from the most recent research to clinical practice," says Gregory A. Brent, MD, Professor of Medicine and Physiology, David Geffen School of Medicine at the University of California Los Angeles and President of the ATA.

"Thyroid disease in pregnancy is common, clinically important, and time-sensitive, and our knowledge about it is rapidly changing. This ATA Guideline will disseminate this new information both widely and rapidly to improve patient care, establish what we believe is optimal care for the pregnant woman and her unborn child, and drive future research to further improve our understanding and patient outcomes," says Richard T. Kloos, MD, Professor, The Ohio State University and Secretary/Chief Operating Officer of the ATA.

Email or share this story:

Saturday, September 3, 2011

Turtles next to lizards on family tree, discovery based on microRNAs shows

ScienceDaily (July 25, 2011) — Famous for their sluggishness, turtles have been slow to give up the secrets of their evolution and place on the evolutionary tree. For decades, paleontologists and molecular biologists have disagreed about whether turtles are more closely related to birds and crocodiles or to lizards. Now, two scientists from the Mount Desert Island Biological Laboratory in Bar Harbor, Maine, and their colleagues from Dartmouth College and Harvard and Yale Universities have developed a new technique using microRNAs for classifying animals, and the secret is out. Turtles are closer kin to lizards than crocodiles.See Also:Plants & AnimalsFrogs and ReptilesBiologyNew SpeciesEarth & ClimateDesertReferenceTurtleSnapping turtleReptileSea turtle

To reach their conclusion, published in Biology Letters, the research team looked at a newly discovered class of molecules called microRNA. Most of the genetic material or DNA that scientists study provides the code for building proteins, large molecules that form an essential part of every organism. But microRNAs are much smaller molecules that can switch genes on and off and regulate protein production. They are also remarkably similar within related animal groups and provide important clues for identification.

"Different microRNAs develop fairly rapidly in different animal species over time, but once developed, they then remain virtually unchanged," said Kevin Peterson, a paleobiologist at MDIBL and Dartmouth College. "They provide a kind of molecular map that allows us to trace a species' evolution."

Peterson worked with Ben King, a bioinformatician at MDIBL. "My role in the study was to enhance our software so we could find new and unique microRNAs in the lizard genome," King said. "We identified 77 new microRNA families, and four of these turned out to also be expressed in the painted turtle. So we had the evidence we needed to say that turtles are a sister group to lizards and not crocodiles."

Though few creatures have been as puzzling as the turtle, the research team plans to use its microRNA analysis on other animals to help determine their origins and relationships as well. It is also developing a web-based platform to share the software with other researchers around the world.

In addition to King and Peterson, the research team included Tyler Lyson and Jacques Gauthier from Yale University, Eric Sperling from Harvard University, and Alysha Heimberg from Dartmouth College.

Email or share this story:

Underwater video camera opens window into the behavior of jellyfish

ScienceDaily (July 25, 2011) — MBL Whitman Center researchers are testing a new underwater video camera system that will allow scientists to study the propulsion and behavior of jellies in their natural habitat.See Also:Plants & AnimalsSea LifeBiochemistry ResearchMarine BiologyWild AnimalsDevelopmental BiologyNatureReferenceJellyfishEcological nicheSeagrassMarine biology

In the lab, you can get a sense for how a jelly swims and captures its prey, explains Sean Colin, a marine ecologist at Roger Williams University, who helped to develop the system, called a self-contained underwater velocimetry apparatus, or SCUVA for short. But what's missing is the influence that ocean currents, nearly impossible to accurately mimic in an artificial setting, have on these processes. "That's what we need this system to answer," says Colin. "How important is this natural background flow to determining who they feed on and how much they're able to ingest?"

This summer, Colin, along with colleague John Costello, a biology professor at Providence College, will use the SCUVA to observe the warty comb jelly, a native species in plentiful supply in the waters off the coast of Woods Hole, Massachusetts. "Primarily what we're interested in is understanding how jellyfish and ctenophores (like these comb jellies) interact with their surrounding fluid, because that influences how they swim, who they eat and, ultimately, their impact on the ecosystem," says Colin. "The SCUVA is allowing us to do that."

Email or share this story: